Commentary: Paynter–A Profile in Courage
Steve Haskin
October 7, 2012
Steve Haskin shares his thoughts on racehorse Paynter’s multiple medical battles and his recovery.
Prevention and treatment for problems of the equine foot
Steve Haskin shares his thoughts on racehorse Paynter’s multiple medical battles and his recovery.
Endocrinology researchers met to discuss equine metabolic syndrome (EMS) and equine Cushing’s disease (PPID).
Paynter has “beaten laminitis” and will be able to race again if he beats colitis, his owner said Sept. 21.
Don Walsh, DVM, answers questions about The 2012 Equine Endocrinology Summit and how it relates to laminitis.
The coordinators of the ongoing laminitis research project have expanded the inclusion criteria.
The colt continues to make strides towards recovery and a possible return to the racetrack.
Zayat Stables reports that its 3-year-old colt Paynter continues to improve after a rough couple of days.
Haskell Invitational winner Paynter, who was diagnosed with laminitis Sept. 4, was “walking comfortably.”
The USA Equestrian Trust recently granted $10,000 to the AAEP Foundation to support the study.
A look at what it really costs to own a horse besides the initial purchase price.
Researchers are asking for horse owners’ help identifying suitable acute laminitis cases for research.
Virginiamycin is the active ingredient in a veterinary medicine used to prevent laminitis in horses.
The stallion worked July 5 before developing colic and endotoxemia that night. He remains in intensive care.
Laminitis is likely the end product of an array of disease processes, one researcher says.
Cryotherapy prevented further lamellar damage in laminitic horses when used after lameness developed.
Stay on top of the most recent Horse Health news with
